Sangamo Therapeutics Inc (NAS:SGMO)
$ 2.16 0.42 (24.14%) Market Cap: 449.76 Mil Enterprise Value: 363.62 Mil PE Ratio: 0 PB Ratio: 19.64 GF Score: 42/100

Sangamo Therapeutics Inc Clinical Development Update Call Transcript

Apr 02, 2019 / 12:00PM GMT
Release Date Price: $12.29 (+28.96%)
Operator

Good day, and welcome to the Sangamo Therapeutics clinical development update conference call. This call is being recorded.

I will now pass you over to the coordinator of this event, McDavid Stilwell, Vice President of Corporate Communications and Investor Relations.

McDavid Stilwell
Sangamo Therapeutics, Inc. - VP of Corporate Communications & IR

Hello, and thank you for joining us.

As we begin, I'd like to point out that we will be referencing an accompanying slide presentation today. A link to the slide presentation may be found on our website, sangamo.com, on the Events and Presentations page of the Investors + Media section of the site.

I'd also like to remind everyone that the forward-looking statements that we will discuss during this conference call are based upon the information that we have available today. Forward-looking statements include, but are not limited to, statements related to the potential therapeutic applications for Sangamo's genomic medicine platform, the potential ability of Sangamo's product

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot